Who is Darius Adamczyk and why is his appointment significant for JNJ?

Darius Adamczyk is the Chairman and Chief Executive Officer of Honeywell. His appointment to the Johnson & Johnson Board of Directors brings significant leadership and executive experience from another large, diversified global company, which can offer valuable strategic insights and governance oversight to JNJ.

What committees will Darius Adamczyk serve on?

Mr. Adamczyk will serve as a member of the Board's Audit Committee and the Compensation & Benefits Committee. These are critical committees overseeing financial reporting and executive compensation, respectively.

When do Darius Adamczyk's committee roles become active?

While his appointment to the Board is effective immediately, his roles on the Audit Committee and Compensation & Benefits Committee will become effective starting April 28, 2022.

How will Darius Adamczyk be compensated for his board service?

As a non-employee Director, Mr. Adamczyk will receive compensation as outlined in the 'Director Compensation' section of Johnson & Johnson's 2022 Proxy Statement.

JNJ 8-K: Leadership Changes

Summary

Johnson & Johnson (JNJ) has announced a significant addition to its Board of Directors with the appointment of Darius Adamczyk, Chairman and CEO of Honeywell, effective immediately as of February 15, 2022. Mr. Adamczyk brings extensive leadership experience, having helmed a major industrial conglomerate, which is likely to be a valuable asset to JNJ's strategic direction and oversight. His appointment suggests a focus on strengthening the board's expertise in areas relevant to a large, diversified healthcare company.

Key Highlights

1Darius Adamczyk, Chairman and CEO of Honeywell, appointed to JNJ's Board of Directors.
2Appointment is effective immediately as of February 15, 2022.
3Mr. Adamczyk will join the Board's Audit Committee and Compensation & Benefits Committee.
4His committee memberships will be effective from April 28, 2022.
5Mr. Adamczyk will be compensated as a non-employee director according to the company's proxy statement.
6This filing includes an attached press release announcing the appointment as Exhibit 99.1.

JOHNSON & JOHNSON 8-K Report, Executive Changes (Feb 16, 2022)

Summary

Key Highlights

Frequently Asked Questions